title: Molecular variants of cholecystokinin after endogenous stimulation in humans: a time study.
abstract: The time-dependent release of molecular variants of cholecystokinin (CCK) into the circulation was studied before and 1, 2, and 4 h after a test meal in six healthy volunteers. At each time period, 100 ml of blood were drawn in a manner to inhibit CCK degradation. Plasma was formed and CCK concentrated by Sep-Pak C18 cartridge chromatography. Molecular variants of CCK and gastrin were well separated from each other by high-performance liquid chromatography (HPLC). Molecular forms of CCK and gastrin were measured by radioimmunoassay using an antibody that requires the presence of the carboxyl-terminal phenylalanine amide for full recognition, implying that biologically active forms were detected. HPLC elution positions of gastrin forms were determined using a gastrin-specific antibody. Chromatographic separation of CCK from gastrin forms was complete, allowing separate integration of gastrin and CCK forms. Therefore no subtraction of gastrin-like immunoreactivity from CCK-like immunoreactivity (CCK-LI) was necessary and CCK-LI could be directly determined. Peaks of CCK-LI were integrated in the column eluates and the plasma concentrations were calculated. Total plasma CCK-LI rose from a value of 2.4 +/- 0.6 pM before the test meal to 6.4 +/- 0.8, 6.6 +/- 0.9, and 5.8 +/- 1.2 pM 1, 2, and 4 h postprandially. The major molecular forms released into the circulation eluted on HPLC in the position of CCK-58 and CCK-39 (which coelutes with CCK-33). Minor amounts were detected in the position of CCK-8. There was no significant difference in the relative proportions of the molecular forms released at the different time periods.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Gastroenterology and Surgery, Harbor-University of California, Los Angeles, Medical Center, Torrance 90509.
authors.forename: V E
authors.initials: VE
authors.lastname: Eysselein
authors.forename: G A
authors.initials: GA
authors.lastname: Eberlein
authors.forename: W H
authors.initials: WH
authors.lastname: Hesse
authors.forename: M
authors.initials: M
authors.lastname: Schaeffer
authors.forename: D
authors.initials: D
authors.lastname: Grandt
authors.forename: R
authors.initials: R
authors.lastname: Williams
authors.forename: H
authors.initials: H
authors.lastname: Goebell
authors.forename: J R
authors.initials: JR
authors.lastname: Reeve
mesh_terms: D000818:Animals; D002766:Cholecystokinin / Q000031:analogs & derivatives* / Q000097:blood* / Q000302:isolation & purification; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004285:Dogs; D014644:Genetic Variation; D006801:Humans; D007413:Intestinal Mucosa / Q000032:analysis; D007421:Intestine, Small / Q000032:analysis
chemical_list: D002766:Cholecystokinin